- Home
- JANX vs BATRK Comparison
JANX vs BATRK Comparison
Compare JANX & BATRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- BATRK
- Stock Information
- Founded
- JANX 2017
- BATRK 1991
- Country
- JANX United States
- BATRK United States
- Employees
- JANX N/A
- BATRK N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- BATRK Broadcasting
- Sector
- JANX Health Care
- BATRK Industrials
- Exchange
- JANX Nasdaq
- BATRK Nasdaq
- Market Cap
- JANX 2.2B
- BATRK 2.5B
- IPO Year
- JANX 2021
- BATRK N/A
- Fundamental
- Price
- JANX $26.81
- BATRK $39.83
- Analyst Decision
- JANX Strong Buy
- BATRK Strong Buy
- Analyst Count
- JANX 8
- BATRK 2
- Target Price
- JANX $91.25
- BATRK $56.50
- AVG Volume (30 Days)
- JANX 784.7K
- BATRK 280.2K
- Earning Date
- JANX 05-06-2025
- BATRK 05-07-2025
- Dividend Yield
- JANX N/A
- BATRK N/A
- EPS Growth
- JANX N/A
- BATRK N/A
- EPS
- JANX N/A
- BATRK N/A
- Revenue
- JANX $10,588,000.00
- BATRK $662,748,000.00
- Revenue This Year
- JANX N/A
- BATRK $9.33
- Revenue Next Year
- JANX $289.47
- BATRK $8.17
- P/E Ratio
- JANX N/A
- BATRK N/A
- Revenue Growth
- JANX 30.99
- BATRK 3.45
- 52 Week Low
- JANX $26.39
- BATRK $35.81
- 52 Week High
- JANX $71.71
- BATRK $44.43
- Technical
- Relative Strength Index (RSI)
- JANX 29.87
- BATRK 52.20
- Support Level
- JANX $29.77
- BATRK $38.92
- Resistance Level
- JANX $32.00
- BATRK $41.00
- Average True Range (ATR)
- JANX 1.44
- BATRK 0.78
- MACD
- JANX -0.00
- BATRK 0.06
- Stochastic Oscillator
- JANX 7.01
- BATRK 56.02
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.
About BATRK Atlanta Braves Holdings Inc. Series C
Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include, baseball which generates key revenue, and mixed-use development.